Revenio Group Oyj — Director's Dealing 2022

Oct 13, 2022

Revenio Group Corporation: Managers' Transactions – Kate Taylor

Revenio Group Corporation, Managers' transactions, October 13, 2022 at 10.30 a.m. (EEST)

Revenio Group Oyj: Managers' Transactions – Kate Taylor

____________________________________________

Person subject to the notification requirement Name: Kate Taylor Position: Other senior manager

Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 20339/5/4 ____________________________________________

Transaction date: 2022-10-11 Venue not applicable Instrument type: SHARE ISIN: FI0009010912 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details (1): Volume: 395 Unit price: 0 EUR Aggregated transactions (1): Volume: 395 Volume weighted average price: 0 EUR

For further information, please contact:

CFO Robin Pulkkinen, tel. +358 50 505 9932 robin.pulkkinen@revenio.fi www.revenio.fi

DISTRIBUTION: Nasdaq Helsinki Ltd Main media www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.

In 2021, the Group's net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Kate Taylor